Neue Wirkstoffmischungen, Diese Enthaltende Zusammensetzungen und Ihre Verwendung gegen Allergien Und/oder Entzündungen

Details

Veröffentlichungs-Nr.

EP4653006

Aktenzeichen

EP25177703

Anmeldetag

20. Mai 2025

Veröffentlichung

26. November 2025

Rechtsraum

EP

IPC

A61K36/185A61K31/352A61K35/741A61K35/747A61K36/28A61K36/324A61K36/35A61K36/535A61K36/73A61P1/00A61P19/02A61P29/00A61P11/06A61P11/14A61P37/00

Abstract

The present invention relates to a mixture comprising or, alternatively, consisting of boswellia, blackcurrant, helichrysum, perilla, quercetin and, optionally, at least one ingredient selected from the group comprising or, alternatively, consisting of a feverfew extract, apple extract, elderberry extract, one or more strains of probiotic bacteria and/or mixtures thereof, useful in the treatment of allergic and/or inflammatory conditions and symptoms, in particular allergic inflammation, on the one hand, and autoimmune and systemic inflammation, on the other. Furthermore, the invention also refers to pharmaceutical compositions and/or compositions for medical devices (Regulation (EU) 2017/745) and/or nutraceuticals and/or food which comprise such novel mixture and to their use in therapy, in the treatment of allergic and/or inflammatory states and symptoms, in particular allergic inflammation, on the one hand, and autoimmune and systemic inflammation, on the other.

Anmelder

Firma

Global Pharmacies Partner S.R.L. in Forma Abbreviata G.P.P. S.R.L.

Land

🇮🇹 Italien

Fachgebiete